An April 17 column, World Food Shortage Stock Plays, incorrectly described Eden Biosciences (EDEN) as a producer of the Messenger product. The micro-cap company, in fact, only markets the product through its small home and garden distribution business. TheStreet.com regrets the error. ( Corrected April 18)
An April 18 article, Honeywell Boosts Sales Forecast, incorrectly stated that the company is a component of the Dow Jones Industrial Average. Honeywell (HON:NYSE) was removed from the Dow in February. TheStreet.com regrets the error. ( Corrected April 18)
An April 17 column, Dykstra's DITM Call: Forest Labs, misstated the price of the Forest Labs (FRX) calls he was considering. He intended to say the 10 November 30 (FRXKG) calls for $7.50 or better, not the 35 calls.
In an April 15 column, AMAG's Iron Drug Put to the Fire, the dosing of ferumoxytol was mischaracterized. Ferumoxytol is given via two, 17-second injections, not as a single, 15-minute infusion as previously stated. TheStreet.com regrets the error. ( Corrected April 15)
An April 14 RealMoney.com Columnist Conversation post, Notable 52-Week Highs, incorrectly identified Dell (DELL) as hitting a 52-week high on April 11. The stock, in fact, hit a 52-week low that day. TheStreet.com regrets the error. ( Corrected April 14)
An April 1 column, Tuesday's Small-Cap Winners & Losers, erronously presented Kandi's (KNDI) full-year 2007 revenue and full-year 2006 net income figures in billion-dollar figures; the figures are actually million-dollar amounts. TheStreet.com regrets the errors. ( Corrected April 1)